Healthy Extracts Inc. achieved a milestone $4.5 million in revenue for fiscal year 2025, propelled by the strategic acquisition of Gummy USA LLC and innovation in gel-based and precision-dosed gummy supplements. The company’s leadership overhaul and focus on integrating pharmaceutical-grade gummy manufacturing underpin its growth momentum. However, Healthy Extracts continues to grapple with operating losses amid investments in clinical validation and integration costs, resulting in a negative return on equity. Future success hinges on managing financial constraints while scaling multi-channel distribution and operational capabilities.